CSPIA
GILD icon

Cary Street Partners Investment Advisory’s Gilead Sciences GILD Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$468K Sell
3,702
-158
-4% -$20.8K 0.09% 215
2026
Q1 		$538K Sell
3,860
-23
-0.6% -$3.22K 0.14% 166
2025
Q4 		$477K Sell
3,883
-234
-6% -$28.4K 0.13% 171
2025
Q3 		$457K Buy
4,117
+565
+16% +$64.2K 0.19% 119
2025
Q2 		$394K Buy
3,552
+433
+14% +$46.1K 0.19% 127
2025
Q1 		$349K Buy
3,119
+346
+12% +$35.7K 0.2% 131
2024
Q4 		$256K Sell
2,773
-4,196
-60% -$378K 0.17% 138
2024
Q3 		$584K Sell
6,969
-10
-0.1% -$763 0.02% 464
2024
Q2 		$479K Buy
6,979
+650
+10% +$43.4K 0.02% 483
2024
Q1 		$464K Buy
6,329
+16
+0.3% +$1.23K 0.02% 469
2023
Q4 		$511K Buy
6,313
+2,024
+47% +$158K 0.02% 422
2023
Q3 		$321K Buy
4,289
+1,842
+75% +$142K 0.02% 466
2023
Q2 		$189K Buy
2,447
+50
+2% +$3.99K 0.01% 525
2023
Q1 		$199K Sell
2,397
-75
-3% -$6.21K 0.01% 472
2022
Q4 		$212K Sell
2,472
-347
-12% -$27.5K 0.02% 461
2022
Q3 		$174K Buy
2,819
+117
+4% +$7.38K 0.01% 463
2022
Q2 		$167K Buy
+2,702
New +$167K 0.01% 446
2021
Q1 		– Sell
-4,685
Closed -$273K – 358
2020
Q4 		$273K Buy
4,685
+2,617
+127% +$158K 0.05% 267
2020
Q3 		$131K Buy
+2,068
New +$143K 0.03% 328

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cary Street Partners Investment Advisory's GILD Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $20.8K and leaving 3,702 shares worth $468K. The position accounts for 0.09% of the portfolio, ranked #215.

Cary Street Partners Investment Advisory first reported a position in GILD in Q3 2020 and has held it in 19 quarters since. The position peaked at $584K in Q3 2024. 1,686 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cary Street Partners Investment Advisory held 3,702 shares of Gilead Sciences worth $468K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 158 Gilead Sciences shares in Q2 2026, an estimated $20.8K.
  • Gilead Sciences made up 0.09% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #215 holding.
  • Cary Street Partners Investment Advisory first reported a position in Gilead Sciences in Q3 2020 and has held it in 19 quarters since.
  • Cary Street Partners Investment Advisory's Gilead Sciences position peaked at $584K in Q3 2024.
  • 1,686 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.